- Home
- MBRX vs CABR Comparison
MBRX vs CABR Comparison
Compare MBRX & CABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBRX | CABR |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | US | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 12.6M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | MBRX | CABR |
|---|---|---|
| Price | $2.68 | $0.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $105.50 | N/A |
| AVG Volume (30 Days) | 97.5K | ★ 210.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.25 | $0.71 |
| 52 Week High | $7.98 | $1.65 |
Technical Indicators
Market Signals| Indicator | MBRX | CABR |
|---|---|---|
| Relative Strength Index (RSI) | 31.40 | 46.15 |
| Support Level | $4.03 | $0.83 |
| Resistance Level | $5.30 | $0.92 |
| Average True Range (ATR) | 0.36 | 0.11 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 4.36 | 23.03 |
Price Performance
Historical ComparisonAbout MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About CABR Caring Brands Inc.
Caring Brands Inc is a consumer wellness company that supports health and wellness through research and development. Its product pipeline addresses a range of conditions, including hair loss, eczema, burns, and sexual wellness. The majority of revenue is generated from the sale of OTC and consumer products, as well as licensing royalties.